Robert Cascella, Director at Neuronetics, Inc. (STIM), bought 100,000 shares at $0.75 ($75K) on 2024-09-12, disclosed to the SEC on 2024-09-13.
Open-market purchase of $75k STIM by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| STIM | BUY | 2024-06-06 | $205K | — | Filing → |
| STIM | BUY | 2023-09-20 | $52K | — | Filing → |
| KRMD | BUY | 2023-08-17 | $50K | — | Filing → |